2. Membrane Transporter/Ion Channel
  3. URAT1
  4. URAT1 inhibitor 2

URAT1 inhibitor 2 是一种口服有效的URAT1 和 CYP isozyme抑制剂，对 URAT1 介导的 14C-UA 吸收、CYP1A2、CYP2C9 的IC50 分别为 1.36 μM、16.97 μM、5.22 μM。URAT1 inhibitor 2 在高尿酸血症和痛风的研究中是一个有前途的候选活性分子。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

URAT1 inhibitor 2 Chemical Structure

URAT1 inhibitor 2 Chemical Structure

CAS No. : 2803951-18-8

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

URAT1 inhibitor 2 相关抗体

Top Publications Citing Use of Products

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

URAT1 inhibitor 2 is an orally active and potent URAT1 and CYP isozyme inhibitor, with IC50 values of 1.36 μM, 16.97 μM, 5.22 μM for URAT1-mediated 14C-UA uptake, CYP1A2 and CYP2C9, respectively. URAT1 inhibitor 2 is a promising agent candidate in the study of hyperuricemia and gout[1].

IC50 & Target

IC50: 1.36 μM (URAT1-mediated 14C-UA uptake), 16.97 μM (CYP1A2), 5.22 μM (CYP2C9), >20 μM (CYP2C19), >20 μM (CYP2D6), and >20 μM (CYP3A4M)[1].
体外研究
(In Vitro)

URAT1 inhibitor 2 (compound 23) (0-50 μM, 3-20 min) inhibits URAT1-mediated 14C-UA uptake (IC50 = 1.36 μM) and CYP cells activity[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

URAT1 inhibitor 2 相关抗体:

Cell Viability Assay

Cell Line: Human URAT1, CYP cells[1]
Concentration: 0, 0.05, 0.15, 0.5, 1.5, 5.0, 15, and 50 μM
Incubation Time: 3-20 min
Result: Inhibited URAT1-mediated 14C-UA uptake and CYP cells activity.
体内研究
(In Vivo)

URAT1 inhibitor 2 (Intravenous at 2 mg/kg or orally at 10 mg/kg) has excellent pharmacokinetic properties with the oral bioavailability of 59.3%[1].
URAT1 inhibitor 2 (4, 2, 1, 0.5, and 0.25 mg/kg; Orally) shows orally active and outstanding SUA-lowering activity with a dose-dependent manner in acute hyperuricemia mice[1].
URAT1 inhibitor 2 (1000 mg/kg, intragastric administration, once) shows favorable safety profiles and no obvious acute toxicity[1].
Pharmacokinetic Parameters of URAT1 inhibitor 2 in male Sprague-Dawley rats[1].

parameter unit p.o. i.v.
compoundmax (h) 23 23
AUC (0-t) ng/mL·h 48754.6 16344.8
AUC (0-∞) ng/mL·h 48781.5 16448.8
MRT (0-∞) h 3.3 1.0
t1/2 h 2.2 1.8
Tmax h 0.3
Cmax ng/mL 19185.0
CL mL/min/kg 2.2
F % 59.3

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague-Dawley rats (n=10)[1]
Dosage: 2 mg/kg (intravenous) or 10 mg/kg (oral administration)
Administration: Intravenous or oral administration
Result: Achieved excellent pharmacokinetic properties with the oral bioavailability of 59.3%.
Animal Model: Acute hyperuricemia mice[1]
Dosage: 4, 2, 1, 0.5, and 0.25 mg/kg
Administration: Orally, once
Result: Showed outstanding SUA-lowering activity.
Animal Model: Kunming mice[1]
Dosage: 1000 mg/kg
Administration: Itragastric administration, once
Result: Showed favorable safety profiles and no obvious acute toxicity.
分子量

456.36

Formula

C21H18BrN3O2S
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

URAT1 inhibitor 2 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

URAT1 inhibitor 22803951-18-8URAT1Urate transporter 1SLC22A12Serum uric acidAcute hyperuricemiaGoutCYP isozymeLow toxicityPharmacokinetic propertiesInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
URAT1 inhibitor 2
目录号：
HY-143906
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z